Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.25.0.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 5,716,830 $ 1,658,574
Selling, general and administrative 5,227,113 6,651,624
Total operating expenses 10,943,943 8,310,198
Gain on sale of ENTADFI® assets 695,216 918,372
Operating loss from continuing operations (10,248,727) (7,391,826)
Non-operating income (expenses):    
Gain on extinguishment of debt 8,624,778 0
Change in fair value of equity securities (349,078) (379,898)
Other income, net 163,124 104,341
Total non-operating income (expenses) 8,438,824 (275,557)
Net loss from continuing operations (1,809,903) (7,667,383)
Net loss from discontinued operations, net of taxes (7,135,444) (608,598)
Net income (loss) $ (8,945,347) $ (8,275,981)
Net loss from continuing operations per basic and diluted common shares outstanding (in dollars per share) $ (0.01) $ (0.08)
Net loss from discontinued operations per basic and diluted common shares outstanding (in dollars per share) (0.05) (0.01)
Net loss per basic and diluted common shares outstanding (in dollars per share) $ (0.06) $ (0.08)
Basic and diluted weighted average common shares outstanding (in shares) 146,383,920 100,601,946